US Patent 10227325 Antiproliferative compounds, and their pharmaceutical compositions and uses
Patent 10227325 was granted and assigned to Celgene on March, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 28, 2018
0
Date of Patent
March 12, 2019
0
Patent Applicant
Patent Application Number
15908366
0
Patent Citations Received
Patent Inventor Names
Matthew D. Correa
0
John Sapienza
0
Joshua Hansen
0
Matthew D. Alexander
0
Raj Kumar Raheja
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10227325 Antiproliferative compounds, and their pharmaceutical compositions and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
